Reckitt research on ‘Ibuprofen, other NSAIDs and COVID‑19’ published in Inflammopharmacology

Our publication, in the peer reviewed academic journal Inflammopharmacology, reviews all the key literature in the field, including our own groundbreaking research, concluding that the scientific evidence overwhelmingly refutes the speculation that ibuprofen worsens outcomes in COVID-19.

The release as fetched from its publisher. reckitt.com ↗